BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24732135)

  • 21. Expression of p63 (TA and deltaN isoforms) in human primary well differentiated buccal carcinomas.
    Chen YK; Hsue SS; Lin LM
    Int J Oral Maxillofac Surg; 2004 Jul; 33(5):493-7. PubMed ID: 15183414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of the oncostatin M receptor in cervical squamous cell carcinoma cells is associated with a pro-angiogenic phenotype and increased cell motility and invasiveness.
    Winder DM; Chattopadhyay A; Muralidhar B; Bauer J; English WR; Zhang X; Karagavriilidou K; Roberts I; Pett MR; Murphy G; Coleman N
    J Pathol; 2011 Nov; 225(3):448-62. PubMed ID: 21952923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical WWOX Expression and Association with Angiogenesis, p53 Expression, Cell Proliferation and Clinicopathological Parameters in Cervical Cancer.
    Seabra MAL; Cândido EB; Vidigal PVT; Lamaita RM; Rodrigues AN; Silva Filho ALD
    Rev Bras Ginecol Obstet; 2018 Feb; 40(2):79-85. PubMed ID: 29310145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergetic Effects of Intronic Mature miR-944 and ΔNp63 Isoforms on Tumorigenesis in a Cervical Cancer Cell Line.
    Kim J; Park S; Chang Y; Park KH; Lee H
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32764455
    [No Abstract]   [Full Text] [Related]  

  • 25. Molecular Mechanisms of p63-Mediated Squamous Cancer Pathogenesis.
    Moses MA; George AL; Sakakibara N; Mahmood K; Ponnamperuma RM; King KE; Weinberg WC
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31340447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression and ratio disruption of ΔNp63 and TAp63 isoform equilibrium in endometrial adenocarcinoma: correlation with obesity, menopause, and grade I/II tumors.
    Vakonaki E; Soulitzis N; Sifakis S; Papadogianni D; Koutroulakis D; Spandidos DA
    J Cancer Res Clin Oncol; 2012 Aug; 138(8):1271-8. PubMed ID: 22441934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant expression of β-catenin and its association with ΔNp63, Notch-1, and clinicopathological factors in oral squamous cell carcinoma.
    Ravindran G; Devaraj H
    Clin Oral Investig; 2012 Aug; 16(4):1275-88. PubMed ID: 21881870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DeltaNp63 isoforms differentially regulate gene expression in squamous cell carcinoma: identification of Cox-2 as a novel p63 target.
    Boldrup L; Coates PJ; Gu X; Nylander K
    J Pathol; 2009 Aug; 218(4):428-36. PubMed ID: 19391123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-203 represses 'stemness' by repressing DeltaNp63.
    Lena AM; Shalom-Feuerstein R; Rivetti di Val Cervo P; Aberdam D; Knight RA; Melino G; Candi E
    Cell Death Differ; 2008 Jul; 15(7):1187-95. PubMed ID: 18483491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of human beta-defensin 1, 2, and 3 expression in oral squamous cell carcinoma.
    Joly S; Compton LM; Pujol C; Kurago ZB; Guthmiller JM
    Oral Microbiol Immunol; 2009 Oct; 24(5):353-60. PubMed ID: 19702947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific binding and chemotactic activity of mBD4 and its functional orthologue hBD2 to CCR6-expressing cells.
    Röhrl J; Yang D; Oppenheim JJ; Hehlgans T
    J Biol Chem; 2010 Mar; 285(10):7028-34. PubMed ID: 20068036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ZNF750 is a lineage-specific tumour suppressor in squamous cell carcinoma.
    Hazawa M; Lin DC; Handral H; Xu L; Chen Y; Jiang YY; Mayakonda A; Ding LW; Meng X; Sharma A; Samuel S; Movahednia MM; Wong RW; Yang H; Tong C; Koeffler HP
    Oncogene; 2017 Apr; 36(16):2243-2254. PubMed ID: 27819679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential expression of p63 isoforms in normal tissues and neoplastic cells.
    Nylander K; Vojtesek B; Nenutil R; Lindgren B; Roos G; Zhanxiang W; Sjöström B; Dahlqvist A; Coates PJ
    J Pathol; 2002 Dec; 198(4):417-27. PubMed ID: 12434410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ΔNp63 in squamous cell carcinoma: defining the oncogenic routes affecting epigenetic landscape and tumour microenvironment.
    Gatti V; Fierro C; Annicchiarico-Petruzzelli M; Melino G; Peschiaroli A
    Mol Oncol; 2019 May; 13(5):981-1001. PubMed ID: 30845357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short interfering RNA targeting Net1 reduces the angiogenesis and tumor growth of in vivo cervical squamous cell carcinoma through VEGF down-regulation.
    Zhang Y; Xia P; Zhang W; Yan M; Xiong X; Yu W; Song E
    Hum Pathol; 2017 Jul; 65():113-122. PubMed ID: 28511963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DeltaNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neck.
    Boldrup L; Coates PJ; Gu X; Nylander K
    J Pathol; 2007 Dec; 213(4):384-91. PubMed ID: 17935121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospero homeobox 1 mediates the progression of gastric cancer by inducing tumor cell proliferation and lymphangiogenesis.
    Park KJ; Cho SB; Park YL; Kim N; Park SY; Myung DS; Lee WS; Kweon SS; Joo YE
    Gastric Cancer; 2017 Jan; 20(1):104-115. PubMed ID: 26759228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated expression of ΔNp63 in advanced esophageal squamous cell carcinoma.
    Kumakura Y; Rokudai S; Iijima M; Altan B; Yoshida T; Bao H; Yokobori T; Sakai M; Sohda M; Miyazaki T; Nishiyama M; Kuwano H
    Cancer Sci; 2017 Nov; 108(11):2149-2155. PubMed ID: 28892579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and regulation of the ΔN and TAp63 isoforms in salivary gland tumorigenesis clinical and experimental findings.
    Mitani Y; Li J; Weber RS; Lippman SL; Flores ER; Caulin C; El-Naggar AK
    Am J Pathol; 2011 Jul; 179(1):391-9. PubMed ID: 21703418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long non-coding RNA SNHG1 regulates zinc finger E-box binding homeobox 1 expression by interacting with TAp63 and promotes cell metastasis and invasion in Lung squamous cell carcinoma.
    Zhang HY; Yang W; Zheng FS; Wang YB; Lu JB
    Biomed Pharmacother; 2017 Jun; 90():650-658. PubMed ID: 28415044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.